Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection

Pediatric Infectious Disease Journal

Volumn 19, Issue 1, 2000, Pages 52-56

  Gürakan, Figen ^a   Koçak, Nurten ^a   Özen, Hasan ^a   Yüce, Aysel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Chronic hepatitis B; High dose; Interferon alpha 2b; Standard dose

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASTHENIA; CELLULITIS; CHILD; CHILDHOOD DISEASE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; HAIR LOSS; HEPATITIS B; HUMAN; MALE; MYALGIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; WEIGHT REDUCTION;

EID: 0343920816     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200001000-00011     Document Type: Article

References (21)

1. Arnot R. The evolving efforts to control hepatitis B virus. Pediatr Infect Dis J 1998;17: S26-9.
2. Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32: 294-8.
3. Ruiz-Moreno M, Rua M, Molina J, et al. Prospective randomised controlled trial of interferon alpha in children with chronic hepatitis B. Hepatology 1991;13:1035-9.
4. Ruiz- Moreno M, Jimenez J, Porres J, Bartolome J, Moreno A, Carreno V. A controlled trial of recombinant interferon alpha in Caucasian children with chronic hepatitis B. Digestion 1990;45:26-33.
5. Sokal E, Wirth S, Goyers P, Depreterre A, Cornu C. Interferon alfa 2b therapy in children with chronic hepatitis B. Gut 1993; 34(Suppl 2):S87-90.
6. Torre D, Tambini R. Interferon alpha therapy for chronic hepatitis B in children; a meta-analysis. Clin Infect Dis 1996;23:131-7.
7. Ikeda K, Saitah S, Suzuki Y, et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus. Cancer 1998;82:627-35.
8. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon ala: an economic appraisal. Hepatology 1995;22:1863-73.
9. Krosgsgaard K, Bindslev N, Christensen E, et al. The treatment effect of alpha interferon in chronic hepatitis B is independent of pretreatment variables: results based on individual patient data from 10 controlled trials. J Hepatol 1994;21:649-55.
10. Fattovich G, Giustina G, Realdi G, Cuirocher R, Schalm SW, EUROHEP. Long term outcome of hepatitis B e antigen positive patients with compensated cirrhosis treated with interferon alpha. Hepatology 1997;26:1338-42.
11. Ruiz-Moreno M. Chronic hepatitis B in children: natural history and treatment. J Hepatol 1993;17(Suppl 3):S64-6.
12. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
13. Bruguera M, Amat L, Garcia O, et al. Treatment of chronic hepatitis B in children with recombinant alpha interferon: different response according to age at infection. J Clin Gastroenterol 1993;17:296-9.
14. Lai CL, Lin HJ, Lau JN, et al. Effect of recombinant alpha interferon with or without prednisone in Chinese HBs Ag carrier children. Q J Med 1991;78:155-63.
15. Ozen H, Koçak N, Yüce A, Gürakan F. Retreatment with higher dose interferon alpha in children with chronic hepatitis B infection. Pediatr Infect Dis J 1999;18:694-7.
16. Jonas MM. Interferon alpha for viral hepatitis. J Pediatr Gastroenterol Nutr 1996;23:93-106.
17. Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to alpha interferon therapy? A statistical analysis of predictive factors. Hepatology 1989;10:761-3.
18. Ozen H, Koçak N, Gürakan F, Yüce A. Long-term follow-up of children with chronic hepatitis B treated with interferon alpha 2a. Presented at the VIII International Symposium on Viral Hepatitis, Madrid, January 22 to 24, 1998, p. 118.
19. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C. Gastroenterology 1995;108: 1104-9.
20. Bayraktar Y, Köseoglu T, Temizer A, et al. Different response rate to interferon in chronic hepatitis B: importance of precore mutant and serum ferritin level. Turk J Gastroenterol 1996; 7:199-204.
21. Fattovich G, Giustina G, Favarato S, Ruol A, Investigation of the Italian Association for the Study of Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alpha interferon. J Hepatol 1996;24:38-47.